Correlation of Visuospatial Ability and EEG Slowing in Patients with Parkinson's Disease

Parkinson’s Disease

Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease

JAMA Neurol.

De Pablo-Fernández E, Lees AJ, Holton JL, Warner TT

doi: 10.1001/jamaneurol.

Parkinson’s Disease

Slow-wave sleep and motor progression in Parkinson disease

Ann Neurol.

Schreiner SJ, Imbach LL, Werth E, Poryazova R, Baumann-Vogel H, Valko PO, Murer T, Noain D, Baumann CR

doi: 10.1002/ana.25459.

Predicting progression in patients with Parkinson's disease

Lancet Neurol.

Blauwendraat C, Bandrés-Ciga S, Singleton AB

doi: 10.1016/

Parkinson’s DiseaseAnxiety and Depression

Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study

Lancet Neurol.

Martínez-Fernández R, Rodríguez-Rojas R, Del Álamo M, Hernández-Fernández F, Pineda-Pardo JA, Dileone M, Alonso-Frech F, Foffani G, Obeso I, Gasca-Salas C, de Luis-Pastor E, Vela L, Obeso JA

doi: 10.1016/

RECOMMENDED

Parkinson’s Disease

Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease

Parkinsonism Relat Disord.

Contin M, Lopane G, Mohamed S, Calandra-Buonaura G, Capellari S, De Massis P, Nassetti S, Perrone A, Riva R, Sambati L, Scaglione C, Cortelli P

doi: 10.1016/j.parkreldis.

Recommendations for the Treatment of Patients With Parkinson Disease During Ramadan.

JAMA Neurol.

Damier P, Al-Hashel J

doi: 10.1001/jamaneurol.

Aging and Cognitive Functions

The patient's perspective: The effect of levodopa on Parkinson symptoms

Parkinsonism Relat Disord.

Zach H, Dirkx M, Pasman JW, Bloem BR, Helmich RC

doi: 10.1016/

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation

Lancet Neurol.

Latourelle JC, Beste MT, Hadzi TC, Miller RE, Oppenheim JN, Valko MP, Wuest DM, Church BW, Khalil IG, Hayete B, Venuto CS

doi: 10.1016/

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Lancet Neurol.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A

doi: 10.1016/S1474-

Related content

Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease

Slow-wave sleep and motor progression in Parkinson disease

Predicting progression in patients with Parkinson's disease

Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study

Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease

Recommendations for the Treatment of Patients With Parkinson Disease During Ramadan.

The patient's perspective: The effect of levodopa on Parkinson symptoms

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial